Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies ; volume:33 ; number:5 ; day:16 ; month:9 ; year:2019 ; pages:571-579 ; date:10.2019
BioDrugs ; 33, Heft 5 (16.9.2019), 571-579, 10.2019
- Urheber
-
Wang, Ellen Q.
Bukowski, Jack F.
Yunis, Carla
Shear, Charles L.
Ridker, Paul M.
Schwartz, Pamela F.
Baltrukonis, Daniel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-019-00375-0
- URN
-
urn:nbn:de:101:1-2020013012334473754585
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Ellen Q.
- Bukowski, Jack F.
- Yunis, Carla
- Shear, Charles L.
- Ridker, Paul M.
- Schwartz, Pamela F.
- Baltrukonis, Daniel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Establishment of anti-mesothelioma monoclonal antibodies
Anti-Bodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Anti-CCP antibodies and bone
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Establishment of anti-mesothelioma monoclonal antibodies
Anti-Bodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Anti-CCP antibodies and bone
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Establishment of anti-mesothelioma monoclonal antibodies
Anti-Bodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Anti-CCP antibodies and bone